Demographic, virological and clinical characteristics of the on-treatment population.

Legend: number of cases (N); standard deviation (SD); Body mass index (BMI); kilograms (kg); meters (m); acquired immunodeficiency syndrome (AIDS); injecting drugs user (IDU); highly active antiretroviral treatment (HAART); human immunodeficiency virus (HIV); hepatitis C virus (HCV); alanine aminotransferase (ALT); low-density lipoprotein (LDL); interleukin 28B (IL28B); cytosine (C); thymine (T).
*Classified on the basis of Center for Disease Control and Prevention (CDC) recommendations (Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 years and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR 2008; 57 (No RR-10): 1–14).
†HIV viral load was measured by PCR (CobasTaqMan, Roche Diagnostic Systems Inc., Pleasanton, CA, USA), detection limit set at 20 IU/mL.
‡Fibrosis stage was determined by liver biopsy according to METAVIR fibrosis score staging or using liver transient elastography (FibroScan, Echosens, Paris).
§Available in 148 (90.8%) patients.